Transcatheter Annuloplasty for Tricuspid Regurgitation – Insights from the TITAN Registry

F. Rudolph (Bad Oeynhausen)1, K. Friedrichs (Bad Oeynhausen)2, M. I. Körber (Köln)3, A. Narang (Chicago)4, M. Kassar (Bern)5, A. Sánchez-Recalde (Hospital Universitario Ramón y Cajal)6, I. Mattig (Berlin)7, R. Pfister (Köln)3, J. L. Zamorano (Madrid)8, H. Dreger (Berlin)9, C. Davidson (Chicago)4, V. Rudolph (Bad Oeynhausen)1, M. Gercek (Bad Oeynhausen)1
1Herz- und Diabeteszentrum NRW Allgemeine und Interventionelle Kardiologie/Angiologie Bad Oeynhausen, Deutschland; 2Herz- und Diabeteszentrum NRW Klinik für Kardiologie Bad Oeynhausen, Deutschland; 3Herzzentrum der Universität zu Köln Klinik III für Innere Medizin Köln, Deutschland; 4Northwestern University Feinberg School of Medicine Chicago, USA; 5Inselspital - Universitätsspital Bern Universitätsklinik für Kardiologie Bern, Schweiz; 6Hospital Universitario Ramón y Cajal Department of Cardiology Hospital Universitario Ramón y Cajal, Spanien; 7Charité - Universitätsmedizin Berlin CC11: Med. Klinik m. S. Kardiologie und Angiologie Berlin, Deutschland; 8University Hospital Ramón y Cajal Department of Cardiology Madrid, Spanien; 9Deutsches Herzzentrum der Charite (DHZC) Klinik für Kardiologie, Angiologie und Intensivmedizin | CBF Berlin, Deutschland

Aims

This study aimed to identify predictors of procedural success in patients undergoing direct annuloplasty (TTVA).

 

Methods

We retrospectively collected clinical and echocardiographic imaging data before, during and after TTVA at four tertiary centers in Europe. The primary endpoint was residual tricuspid regurgitation (TR) of moderate or less; the secondary endpoint was a composite of freedom from all-cause mortality and rehospitalization for heart failure, and New-York Heart Association (NYHA) class ≤ II at one-year follow-up. A two-step regularized regression approach including clinical and echocardiographic parameters was used to identify predictors of the primary endpoint.

 

Results

This study includes data from 225 patients treated at four European centers. The median age was 79 years (IQR: 74-82), with 72.0% being female. TR grade was massive or worse in 65.3%; 40.4% were classified as atrial functional TR. The primary endpoint was achieved in 72.9% of all patients, the secondary endpoint in 48.7%. In the final multivariable logistic regression model, four variables were significantly associated with the primary endpoint: TR vena contracta, bi-commissural tricuspid annulus diameter, tricuspid valve (TV) coaptation gap, and the presence of atrial TR. Among these, the presence of atrial TR yielded the strongest association (OR 2.75, 95% CI: 1.03-7.95, P = 0.049). Sub-analyses revealed higher rates of achieving the primary and secondary endpoints in patients with atrial TR when compared to non-atrial TR.

 

Conclusion

Our study confirms previous findings that atrial functional tricuspid regurgitation appears to be optimally suited for TTVA, yielding high procedural safety and efficacy in this group.